Ваша жизнь в ваших руках. Как понять, победить и предотвратить рак груди и яичников - Джейн Плант (2012)

84. Kolpin, D.A., Furlong, E.T., Meyer, M.T., Thurman, E.M., Zaugg, S.D., Barber, L.B. and Buxton, H.T.; 2002. Pharmaceuticals, Hormones, and Other Organic Wastewater Contaminants in US Streams, 1999–2000: A National Reconnaissance. Environmental Science & Technology, 36, 1202–1211.

85. McQuillan, D., Mullany, J., Parker, J., Mills, D., Sherrell, K. and Chapman, Т.Н., 2000. Drug Residues in Ambient Water: Initial Surveillance in New Mexico, USA. December 2000 Progress Report, html; Morelli, J., 2000. Are Our Medicines Tainting the Environment?

86. McQuillan, D., Mullany, J., Parker, J., Mills, D., Sherrell, K. and Chapman, Т.Н., 2000. Drug Residues in Ambient Water: Initial Surveillance in New Mexico, USA. December 2000 Progress Report, html

87. The Royal Commission on Environmental Pollution, 2003. Chemicals in products: safeguarding the environment and human health. Report 24.

88. Hamburger Umwelt Institute, 1997. Poor Design Practices – gaseous emissions form complex products.

89. Brown, S.K. and Cheng, M., 2000. Volatile Organic Compounds (VOCs) in New Car Interiors. Presented at the 35th International Clean Air & Environment Conference Sydney, 26–30 November 2000.

90.

91. Clapp, R.W and others, 2005. Environmental and occupational causes of cancer. The Lowell Centre for Sustainable Production, University of Massachusetts Lowell.

92. The Globe and Mail, November 22, 2002, page A5. Data point to breast-cancer risk. By Martin Mittelstaedt.

93. Newby, JA. and Howard, C.V, 2006. Environmental influences in cancer aetiology. Journal of Nutritional and Environmental Medicine; 2006, 1-59.

94. Clapp, R.W and others, 2005. Environmental and occupational causes of cancer. The Lowell Centre for Sustainable Production, University of Massachusetts Lowell.

95. Birnbaum, L.S. and Fenton, S.E., 2003. Cancer and developmental exposure to endocrine disruptors. Environmental Health Perspectives, 11 (4), 389–395.

96. www.obgyn.nct/newsrx/womens_health-Colorectal_Cancer-20001214-7.asp

97. theepicstudy

98. www.ucdmc.ucdavis.edu/ucdhs/health/a-z/06BreastCancer/ doc06lowerisk.html

99. Epidem. 1994, 23 (6), 1133–1136.

100. Spurgeon, D., 2006. Vitamin D is associated with a lower risk of cancer. BMJ, 332, 70.

101. Miller, WR. and Sharpe, R.M., 1998. Environmental oestro-gens and human reproductive cancers. Endocrine-Related Cancer, 5, 69–96.

102.

103. Gottlieb, Scott. 2002. Study supports evidence on oral contraception and breast cancer. BMJ, 325, 6 July 2002, 8.

104. Writing Group for the Women’s Health Initiative Investigators. 2002. Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women. Journal of the American Medical Association, 288, № 3.

105. Collaborative Group on Hormonal Factors in Breast Cancer,

1997. Breast cancer and hormone replacement therapy. Lancet,ЪЬЪ, 1047–1059.

106. Schairer, C., Lubin, J., Troisi, R., and others, 2000. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. JAMA, 283(4), 485–491.

107. www.nih.gov/news/pr/nov2002/nichd-29.htm

108. Ross, R.K., Paganini-Hill, A., Wan, P.C. and others, 2000. Effective hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. J Natl Cancer Inst,

92, 328–332. Schairer, C., Lubin, J., Troisi, R. and others. 2000.

Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. JAMA, 283 (4), 485–491.

109. The Times. 15 December 2006.